The human growth hormone gene family is composed of six genes coding for three proteins of physiological and clinical importance: growth hormone (hGH), prolactin (hPrl) and chorionic somatomammotropin (hCS). The correct and regulated expression of these genes is important for maintaining normal growth and development, starting from embryonic life through adulthood. Five of the genes are located on human chromosome 17 within a 60 Kb cluster, where the gene order is: hGH-N, hCS-A, hGH-V and hCS-B, but the sixth gene, hPrl, is located on chromosome 6. The high degree of sequence homology (less than 93%) and clustering suggest that the hGH and hCS genes evolved recently, probably by gene amplification. In spite of their similarity and close proximity, the expression of these genes is strictly tissue specific. hGH-N coding for GH is expressed in the anterior pituitary, while the other four genes, coding for various forms of CS and a rare variant of GH, are expressed in the placenta. On the other hand, the more distantly related Prl gene is also expressed in the anterior pituitary. While the complete structure and chromosomal organization of these genes are known, the mechanisms responsible for their strict tissue specific expression are not understood. We propose to study these mechanisms first by defining the various cis-acting genetic elements responsible for the remarkable differential expression of the hGH-N and hCS-A genes and second by characterizing the trans-acting regulatory factors which recognize these cis-elements. Once such factors are found, they will be purified to near homogeneity and their biological significance will be tested in vivo and in vitro by a variety of genetic and biochemical approaches. Finally, partial amino-acid sequences of the factors, which are of primary importance for conferring tissue specific expression upon these genes, will be determined. In addition, specific antisera will be raised against these factors and together, with oligonucleotide probes which match the protein sequence, will be used for screening of cDNA libraries. We also plan to develop a new approach for detecting clones coding for DNA binding proteins, by screening expression libraries with synthetic oligonucleotide probes which match the recognition sites of the various DNA binding proteins and a genetic selection procedure that will allow direct selection of the gene coding for one of these trans acting factors. Once the appropriate cDNA clones are isolated, they will be used for isolating the regulatory genes which control the expression of the GH gene family. We hope that studying the structure, function and regulation of the regulatory genes will reveal some of the molecular mechanisms which underlie tissue specific gene-expression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK038527-01
Application #
3237912
Study Section
Endocrinology Study Section (END)
Project Start
1987-09-01
Project End
1990-08-31
Budget Start
1987-09-01
Budget End
1988-08-31
Support Year
1
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Baud, V; Liu, Z G; Bennett, B et al. (1999) Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev 13:1297-308
Aronheim, A; Zandi, E; Hennemann, H et al. (1997) Isolation of an AP-1 repressor by a novel method for detecting protein-protein interactions. Mol Cell Biol 17:3094-102
Rosette, C; Karin, M (1995) Cytoskeletal control of gene expression: depolymerization of microtubules activates NF-kappa B. J Cell Biol 128:1111-9
Mercurio, F; DiDonato, J A; Rosette, C et al. (1993) p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction. Genes Dev 7:705-18
Theill, L E; Karin, M (1993) Transcriptional control of GH expression and anterior pituitary development. Endocr Rev 14:670-89
Mercurio, F; Didonato, J; Rosette, C et al. (1992) Molecular cloning and characterization of a novel Rel/NF-kappa B family member displaying structural and functional homology to NF-kappa B p50/p105. DNA Cell Biol 11:523-37
Theill, L E; Hattori, K; Lazzaro, D et al. (1992) Differential splicing of the GHF1 primary transcript gives rise to two functionally distinct homeodomain proteins. EMBO J 11:2261-9
McCormick, A; Brady, H; Fukushima, J et al. (1991) The pituitary-specific regulatory gene GHF1 contains a minimal cell type-specific promoter centered around its TATA box. Genes Dev 5:1490-503
Castrillo, J L; Theill, L E; Karin, M (1991) Function of the homeodomain protein GHF1 in pituitary cell proliferation. Science 253:197-9
Karin, M; Theill, L; Castrillo, J L et al. (1990) Cell type specific expression of the growth hormone gene and its control by GHF-1. Nippon Naibunpi Gakkai Zasshi 66:1205-20

Showing the most recent 10 out of 17 publications